BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 19699756)

  • 1. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
    Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
    Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
    Calvete JJ; Cid P; Sanz L; Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Theakston RD; Warrell DA; Gutiérrez JM
    Am J Trop Med Hyg; 2010 Jun; 82(6):1194-201. PubMed ID: 20519622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of geographical variation of Echis ocellatus, Naja nigricollis and Bitis arietans venoms on their neutralization by homologous and heterologous antivenoms.
    Sánchez A; Coto J; Segura Á; Vargas M; Solano G; Herrera M; Villalta M; Estrada R; Gutiérrez JM; León G
    Toxicon; 2015 Dec; 108():80-3. PubMed ID: 26450770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
    Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
    Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the myotoxic activities of three African Bitis venoms (B. rhinoceros, B. arietans and B. nasicornis) by a polyvalent antivenom.
    Ponte CG; Nóbrega EL; Fernandes VC; da Silva WD; Suarez-Kurtz G
    Toxicon; 2010; 55(2-3):536-40. PubMed ID: 19857507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
    Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria.
    Sánchez LV; Pla D; Herrera M; Chippaux JP; Calvete JJ; Gutiérrez JM
    Toxicon; 2015 Nov; 106():97-107. PubMed ID: 26415904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms.
    Laing GD; Yarleque A; Marcelo A; Rodriguez E; Warrell DA; Theakston RD
    Toxicon; 2004 Jul; 44(1):103-6. PubMed ID: 15225568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
    Habib AG; Warrell DA
    Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids.
    Ramos-Cerrillo B; de Roodt AR; Chippaux JP; Olguín L; Casasola A; Guzmán G; Paniagua-Solís J; Alagón A; Stock RP
    Toxicon; 2008 Dec; 52(8):881-8. PubMed ID: 18926842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches.
    Petras D; Sanz L; Segura A; Herrera M; Villalta M; Solano D; Vargas M; León G; Warrell DA; Theakston RD; Harrison RA; Durfa N; Nasidi A; Gutiérrez JM; Calvete JJ
    J Proteome Res; 2011 Mar; 10(3):1266-80. PubMed ID: 21171584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria.
    Abubakar SB; Abubakar IS; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Laing GD; Theakston RD; Juszczak E; Alder N; Warrell DA;
    Toxicon; 2010 Apr; 55(4):719-23. PubMed ID: 19874841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which antivenom for Cerastes envenoming?].
    Mion G; Larréché S
    Med Sante Trop; 2014; 24(1):105-6. PubMed ID: 24736220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.
    Abubakar IS; Abubakar SB; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Theakston RD; Juszczak E; Alder N; Warrell DA;
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e767. PubMed ID: 20668549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
    Sánchez A; Segura Á; Vargas M; Herrera M; Villalta M; Estrada R; Wu F; Litschka-Koen T; Perry MA; Alape-Girón A; León G
    Toxicon; 2017 Jan; 125():59-64. PubMed ID: 27890775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
    Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
    Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African adders: partial characterization of snake venoms from three Bitis species of medical importance and their neutralization by experimental equine antivenoms.
    Paixão-Cavalcante D; Kuniyoshi AK; Portaro FC; da Silva WD; Tambourgi DV
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003419. PubMed ID: 25643358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Bitis spp. and Echis spp. African snakes.
    Gómez A; Sánchez A; Durán G; Cordero D; Segura Á; Vargas M; Solano D; Herrera M; Chaves-Araya S; Villalta M; Sánchez M; Arguedas M; Díaz C; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010643. PubMed ID: 35960772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays.
    Gutiérrez JM; Tsai WC; Pla D; Solano G; Lomonte B; Sanz L; Angulo Y; Calvete JJ
    Toxicon; 2013 Mar; 64():60-9. PubMed ID: 23313380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.